Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1/2a Study for Treatment of Chronic Diabetic Foot Ulcers (DFU) With the Investigational Allogeneic Cell Therapy Product, hOMSC200

NCT06003530 is registered in ClinicalTrials.gov with Cytora Ltd. as lead sponsor.

NCT NCT06003530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06003530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1/2a Study for Treatment of Chronic Diabetic Foot Ulcers (DFU) With the Investigational Allogeneic Cell Therapy Product, hOMSC200
Lead sponsor
Cytora Ltd.
Phase
Phase 1
Overall status
Unknown status
Start date
January 6, 2022
Completion date
December 31, 2024
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot, diabetic foot ulcer, diabetic foot ulcer neuropathic